Same drugs, valued differently? Comparing comparators and methods used in reimbursement recommendations in Australia, Canada, and Korea

Methods for the economic evaluation of health care programmes, 3rd ed

Grazyna Teresa Adamiak · PubMed Central · 2006 · 962 citations · Full text

Public Affairs, Economics, Health Policy +15

Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs

Peter B. Bach · New England Journal of Medicine · 2009 · 391 citations

Public Affairs, Health Policy, Oncology +12

Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions

Fiona Clement, Anthony Harris, Jing Jing Li et al. · JAMA · 2009 · 340 citations

Pharmacy, Health Policy, Pharmacoeconomics +14

Welfarism vs. extra-welfarism

Werner Brouwer, Anthony J. Culyer, Job van Exel et al. · Journal of Health Economics · 2007 · 324 citations · Full text

Social Sciences, Economics, Health Economics +8

Problems With the Interpretation of Pharmacoeconomic Analyses

Suzanne Hill, Andrew Mitchell, David Henry · JAMA · 2000 · 228 citations

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +15